Results 61 to 70 of about 14,999 (181)
Perioperative use of Impella device in very high-risk coronary artery bypass grafting
This case study presents a high-risk coronary artery bypass grafting (CABG) patient with a recent anterior wall myocardial infarction and severely impaired left ventricular function.
P. L. N. Kapardhi +3 more
doaj +1 more source
Key Clinical Message The MitraClip NT™ system for the treatment of severe mitral valve regurgitation is effective and safe – even for patients suffering from cardiogenic shock.
Dominik Buckert +5 more
doaj +1 more source
ABSTRACT Background The inflammatory response to whole‐body ischemia, as seen in comatose survivors after out‐of‐hospital cardiac arrest (OHCA), is associated with increased morbidity and mortality. Early high‐dose dexamethasone may dampen the inflammatory response, which may diminish secondary brain damage and other organ injury and decrease mortality.
Jo B. Andreasen +12 more
wiley +1 more source
ABSTRACT Background Delirium is a frequent complication in comatose Out‐of‐Hospital Cardiac Arrest (OHCA) survivors requiring postresuscitation intensive care and is associated with higher mortality and longer hospitalization. Despite this, there is no established pharmacologic strategy for delirium prevention in OHCA survivors.
Benedikte Liebetrau +12 more
wiley +1 more source
Angiotensin II type 1 receptor antibodies (AT1R-Ab) are among the most investigated type of non-human leukocyte antigen antibodies in solid organ transplantation, particularly given its association with allograft dysfunction.
Maria T. Gamero, MD +7 more
doaj +1 more source
ABSTRACT Background Intermediate‐high risk pulmonary embolism (PE) represents a clinically challenging subgroup of acute PE, characterized by right ventricular dysfunction and increased risk of hemodynamic deterioration despite treatment with anticoagulation therapy.
Jacob Hindborg Hovmann +11 more
wiley +1 more source
Cardiogenic shock is a dreadful complication of myocardial infarction. Despite widespread use and availability, intra‐aortic balloon pump (IABP) does not reduce mortality nor improves outcomes.
Marco Contarini +8 more
doaj +1 more source
Flecainide overdose – support using an intra-aortic balloon pump
Background Flecainide is an antiarrhythmic agent which is being used increasingly for the management of super-ventricular arrhythmias. Overdose with flecainide is frequently fatal with mortality reported as high as 22% due to arrhythmias, myocardial ...
Brown Peter D +3 more
doaj +1 more source
The answer is an intra-aortic balloon pump [PDF]
Takami, Yoshiyuki, Masumoto, Hiroshi
openaire +2 more sources
BackgroundAcute kidney injury (AKI) is one of the common and severe complications following coronary artery bypass graft (CABG) surgery, significantly increasing patient mortality, complication rates, and length of hospital stay.
Hongyan Chu +5 more
doaj +1 more source

